Why the Certificate of Analysis Matters
When a vial of synthetic research peptide arrives in the laboratory, the accompanying Certificate of Analysis (COA) is not merely administrative paperwork. It is the primary document that links a specific production lot to a defined set of analytical measurements, giving researchers the evidence needed to evaluate whether the material is suitable for a planned experiment. Relying on a peptide without scrutinising its COA introduces uncontrolled variables that can compromise reproducibility, waste reagents, and confound downstream data interpretation.
This guide walks through each major section of a typical peptide COA, explains the analytical techniques behind the reported values, and highlights the questions a researcher should ask before the peptide ever enters a buffer or an assay.
Lot and Batch Identification
The top of a COA carries identifying information that ties the document to one unique production run. Key fields typically include:
- Product name and catalogue number – confirms you have documentation for the correct compound.
- Lot or batch number – should match the number printed on the vial label. A mismatch means the COA does not describe the material in hand.
- Manufacturing date and expiry or retest date – indicates the window during which stored material is expected to meet specification under recommended conditions.
- Storage conditions – commonly −20 °C or −80 °C, often with desiccation; departure from these conditions during shipping or storage may invalidate analytical results.
Always photograph or scan the vial label alongside the COA before proceeding, creating a traceable record in the laboratory notebook.
Amino Acid Sequence and Structural Descriptors
A correctly formatted COA states the full amino acid sequence in single-letter or three-letter code, from N-terminus to C-terminus. Researchers should verify this sequence character by character against the sequence used to design the experiment. Common modifications that must be explicitly listed here include:
- N-terminal acetylation or free amine
- C-terminal amidation or free acid
- Disulfide bridges and their connectivity
- PEGylation, biotin conjugation, or fluorophore labelling
- Phosphorylation, glycosylation, or other post-translational mimetics
The COA should also state the molecular formula and the theoretical molecular weight calculated from the sequence and modifications. These values serve as the reference frame for interpreting mass spectrometry data.
Purity Assessment by HPLC
High-performance liquid chromatography (HPLC), most often reversed-phase HPLC (RP-HPLC) with UV detection at 214 nm or 220 nm, is the standard technique for quantifying purity. The COA should report:
- Purity percentage – expressed as the area percentage of the main peptide peak relative to all integrated peaks in the chromatogram. Research-grade peptides are commonly supplied at ≥95% or ≥98% purity, though the appropriate threshold depends on the assay. Binding studies and structural work generally demand higher purity than initial screening assays.
- Retention time – the time at which the main peak elutes under a defined gradient and column type. This value aids in cross-lot comparisons but is only meaningful when the chromatographic method is fully described.
- Chromatogram image or data file reference – a COA that cites a purity value without attaching or referencing supporting chromatographic data offers limited verifiability.
Impurities visible as minor peaks may represent deletion sequences (peptides missing one or more residues), truncation products, oxidised variants, or reagent carry-over from solid-phase synthesis. High-purity specifications reduce but do not eliminate the presence of these species.
Mass Spectrometry Confirmation
Mass spectrometry (MS) confirms that the observed molecular mass matches the theoretical mass of the intended sequence. Electrospray ionisation (ESI-MS) and matrix-assisted laser desorption/ionisation time-of-flight (MALDI-TOF) are the two methods most frequently used for synthetic peptides.
On the COA, look for:
- Theoretical molecular weight (monoisotopic or average) – calculated from the molecular formula. Note that monoisotopic and average masses differ; the COA should specify which convention is used.
- Observed m/z values and charge states – ESI typically produces multiply charged ions; the COA should show at least one charge state with calculated and observed m/z in agreement within an acceptable tolerance (commonly ±0.5 Da for average mass or ±0.02 Da for high-resolution instruments).
- Spectrum image or peak table – raw data or a representative spectrum image allows the researcher to assess signal quality and check for unexpected adducts or fragmentation artefacts.
A positive MS result confirms molecular identity but does not distinguish between stereoisomers or sequence isomers; those require additional methods such as amino acid analysis or tandem MS (MS/MS).
Additional Analytical Tests
Depending on the supplier and peptide complexity, a COA may include supplementary tests:
- Water content by Karl Fischer titration – synthetic peptides are hygroscopic and frequently contain 5–15% water by mass. Knowing the water content allows more accurate calculation of the true peptide mass when preparing stock solutions.
- Counterion content – trifluoroacetate (TFA) is a common by-product of Fmoc solid-phase synthesis and can affect cell-based assays; some COAs report TFA levels or confirm counterion exchange to acetate.
- Amino acid analysis (AAA) – hydrolysis followed by chromatographic quantification of individual amino acids; provides orthogonal sequence confirmation and absolute quantity data.
- Endotoxin testing – relevant when the peptide will contact cell cultures; reported in EU/mL using Limulus amebocyte lysate (LAL) or recombinant factor C assays.
- Sterility – some suppliers provide sterile-filtered peptides with accompanying sterility test results for cell culture applications.
Net Peptide Content and Quantity
The vial label may state a nominal mass (e.g., 5 mg), but the net peptide content—the fraction of that mass attributable to the peptide itself after accounting for water, counterions, and other non-peptide components—is often lower. Where provided, net peptide content enables accurate preparation of molar stock solutions. If not explicitly stated, researchers can estimate it using water content and purity data, or request quantitative amino acid analysis results from the supplier.
Interpreting the COA in the Context of Your Experiment
A COA documents the material as it left the manufacturing facility. Researchers must consider whether storage, handling, and reconstitution conditions could alter the peptide's characteristics before use. Peptides containing methionine, cysteine, or tryptophan residues are particularly susceptible to oxidation; those with asparagine or glutamine may deamidate over time or under acidic or basic conditions. If a COA is more than 12–18 months old, or if the material has been through multiple freeze-thaw cycles, repeat analytical testing may be warranted before conducting critical experiments.
Cross-referencing the COA purity and identity data with published characterisation data for the same or analogous peptides provides an additional layer of confidence. Significant discrepancies in retention time or observed mass compared with literature values should prompt further investigation before the material is used in quantitative assays.
For research use only. The information presented in this article is intended solely for qualified laboratory researchers working with peptides in a research context. It does not constitute medical, clinical, or therapeutic guidance of any kind, and the peptides described are not intended for human or veterinary administration.